Quarry LP Akero Therapeutics, Inc. Transaction History

Quarry LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.31 - $24.62 $17,394 - $23,389	-950 Reduced 32.2%	2,000 $46.9 Million
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $21,312 - $37,416	1,200 Added 68.57%	2,950 $74.5 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $5,690 - $25,165	500 Added 40.0%	1,750 $40.9 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $51,487 - $65,312	1,250 New	1,250 $63.2 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

Stay updated on Quarry LP with notifications on news.